
Xu Huji Team Uses Universal STAR-T Cell Therapy to Successfully Treat Systemic Lupus Erythematosus
The novel universal STAR-T cell therapy (YTS109) was applied for the first time globally to severe refractory SLE with lupus nephritis. Results published in Nature Medicine showed all patients rapidly reached SRI-4 and achieved sustained benefit.
Shanghai Changzheng Hospital
